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dent predictors of progression to ESRD were creatinine atFibrillary and immunotactoid glomerulonephritis: Distinct enti-
biopsy [2.05 (1.55 to 2.72) P 0.001] and severity of interstitialties with different clinical and pathologic features.
fibrosis [2.01 (1.05 to 3.85) P 0.034]. Although IT had similarBackground. Controversy surrounds the relatedness of fibril-
presentation, histologic patterns, and outcome compared tolary glomerulonephritis (FGN) and immunotactoid glomerulo-
FGN, it had a greater association with monoclonal gammopa-nephritis (IT).
thy (P  0.014), underlying lymphoproliferative disease (P Methods. To better define their clinicopathologic features
0.020), and hypocomplementemia (P  0.032).and outcome, we report the largest single center series of 67
Conclusion. FGN is an idiopathic condition characterizedcases biopsied from 1980 to 2001, including 61 FGN and 6 IT.
by polyclonal immune deposits with restricted gamma isotypes.FGN was defined by glomerular immune deposition of Congo
Most patients present with significant renal insufficiency andred–negative randomly oriented fibrils of 30 nm (mean, 20.1
have a poor outcome despite immunosuppressive therapy, and0.4 nm). IT was defined by glomerular deposition of hollow,
outcome correlates with histologic subtype. By contrast, ITstacked microtubules of  30 nm (mean, 38.2  5.7 nm).
often contains monoclonal IgG deposits and has a significantResults. FGN comprised 0.6% of total native kidney biopsies
association with underlying dysproteinemia and hypocom-and IT was tenfold more rare (0.06%). Deposits in FGN were
plementemia. Differentiation of FGN from the much moreimmunoglobulin G (IgG) dominant and polyclonal in 96%. IgG
rare entity IT appears justified on immunopathologic, ultra-subtype analysis in 19 FGN cases showed monotypic deposits in
structural, and clinical grounds.four (two IgG1 and two IgG4) and oligotypic deposits in 15
(all combined IgG1 and IgG4). In IT, deposits were IgG domi-
nant in 83% and monoclonal in 67% (three IgG1 and one
IgG1). FGN patients were a mean age of 57 years, 92% were Organized fibrillar or microtubular glomerular depos-Caucasian, and 39% were male. At biopsy, FGN patients had
its may be encountered in a variety of renal disorders,the following clinical characteristics (mean, range): creatinine
including amyloidosis, cryoglobulinemic glomerulone-3.1 mg/dL (0.5 to 14), proteinuria 6.5 g/day (0.8 to 25), 60%
microhematuria, and 59% hypertension. Histologic patterns of phritis, lupus nephritis, collagen glomerulopathies, and
FGN were diverse, including diffuse proliferative glomerulo- the entities of fibrillary and immunotactoid glomerulone-
nephritis (DPGN) (nine cases), membranoproliferative glomer- phritis. Fibrillary glomerulonephritis (FGN) is a distinc-ulonephritis (MPGN) (27 cases), mesangial proliferative/scle-
tive but controversial glomerulopathy first reported byrosing (MES) (13), membranous glomerulonephritis (MGN)
Rosenmann and Eliakim in 1977 [1]. This rare disorder(four), and diffuse sclerosing (DS) (eight). The more prolifera-
tive (MPGN and DPGN) and sclerosing (DS) forms presented comprises less than 1% in renal biopsy series and usually
with a higher creatinine and greater proteinuria compared to presents with renal insufficiency, nephrotic range protein-
MES and MGN. Median time to end-stage renal disease uria, and microhematuria [2, 3]. It is characterized patho-(ESRD) was 24.4 months for FGN and mean time to ESRD
logically by the deposition in glomeruli of fibrillar depos-varied by histologic subtype: DS 7 months, DPGN 20 months,
its that generally range from 16 to 24 nm in diameterMPGN 44 months, compared to MES 80 months and MGN
87 months. There was no statistically significant effect of immuno- [2, 3]. These fibrils usually stain for immunoglobulin G
suppressive therapy (given to 36% of FGN patients). By Cox (IgG) and C3, with more variable and weaker positivity
regression (hazard ratio, confidence interval, P value), indepen- for other immunoglobulins [2]. By definition, the glomer-
ular deposits are Congo red–negative, allowing their dif-
ferentiation from amyloid. Hence, synonyms for FGNKey words: fibrillary glomerulonephritis, immunotactoid glomerulo-
nephritis. include “nonamyloidotic fibrillary glomerulonephritis”
and “Congo red–negative amyloidosis-like glomerulopa-Received for publication August 6, 2002
thy” [4–6].and in revised form October 7, 2002
Accepted for publication November 11, 2002 There is considerable debate about the relationship
of FGN to immunotactoid glomerulonephritis (IT), an 2003 by the International Society of Nephrology
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Fig. 1. Electron microscopic features of fibrillary glomerulonephritis (FGN) and immunotactoid glomeronephritis (IT). (A ) An example of FGN
displays intramembranous, randomly oriented fibrils of mean 20 nm diameter that infiltrate and thicken the glomerular basement membrane. The
fibrils lack hollow centers and parallel stacking. Magnification15,000. (B ) An example of IT exhibits subendothelial accumulation of microtubules
of 35 nm diameter with hollow centers arranged in parallel stacks. The microtubules do not infiltrate the glomerular basement membrane.
Magnification 15000.
entity with larger microtubular deposits, usually30 nm identified in a renal allograft was also included in the
in diameter, which are often hollow and arranged in study. FGN was defined as the glomerular deposition of
parallel or stacked arrays [3, 7–12]. Proponents of the fibrils that were (1) randomly oriented; (2) lacked hollow
view that FGN and IT are related entities have argued centers at magnifications of 30,000; (3) measured
that morphologic differences, such as hollow centers and 30 nm in diameter; (4) were Congo red–negative; and
parallel bundling, are merely a function of fibril diameter (5) stained with antisera to immunoglobulins by routine
and the resolution of the electron microscope rather than immunofluorescence (Fig. 1A). IT was defined as glo-
their intrinsic physicochemical properties or etiologic dif- merular microtubular deposits that were (1) oriented
ferences [12]. The identification of underlying dysprotein- in stacked or parallel arrays; (2) had hollow centers at
emia or autoimmune disorders in a subgroup of patients magnifications of 30,000; (3) measured 30 nm in
with the IT pattern has led some investigators to continue diameter; (4) were Congo red–negative; and (5) stained
to split IT from FGN, an entity in which most patients with antisera to immunoglobulins by routine immuno-
have no underlying systemic disorder [9]. Yet, other in- fluorescence (Fig. 1B). For a single case with microtu-
vestigators prefer to use the term IT for both entities, bules measuring less than 30 nm in diameter, a designa-
insisting that there is insufficient knowledge about differ- tion of IT was given because the microtubules had hollow
ences in pathogenesis to justify their distinction on mor- centers and formed parallel arrays. Biopsies with a clini-
phologic grounds alone [7, 8, 12]. copathologic diagnosis of amyloidosis (defined as Congo
In order to enlarge our understanding of the morpho- red–positive fibrils of 8 to 12 nm diameter), cryoglobuli-
logic and clinical features of these controversial entities, nemic glomerulonephritis, lupus nephritis, and collagen
we report the results of renal biopsies from 61 patients glomerulopathy were excluded.
with FGN and from six patients with IT. Our findings Renal biopsies were processed by standard techniques
underscore a more diverse histologic spectrum of FGN for light microscopy, immunofluorescence, and electron
than previously recognized. Based on the clinical, immu-
microscopy. For immunofluorescence, 3 	m cryostat sec-
nopathologic, and ultrastructural differences between
tions were stained with fluorescein isothiocyanate (FITC)-these entities, we advocate the continued segregation of
conjugated rabbit antihuman IgG, IgM, IgA, C3, C1q,FGN from the more rare entity of IT.
kappa light chain and lambda light chain (Dako Corpora-
tion, Carpenteria, CA, USA). IgG subtypes (studied in
METHODS 19 FGN and four IT cases with residual archival frozen
tissue) were analyzed by direct immunofluorescence usingRenal biopsies from 60 patients with FGN and six pa-
polyclonal FITC-conjugated antibodies to IgG1, IgG2,tients with IT were identified retrospectively from among
IgG3 and IgG4 (The Binding Site, Birmingham, UK) at10,108 native kidney biopsies in the files of the Columbia
concentrations standardized by the manufacturer. Elec-University Renal Pathology Laboratory over a period
of two decades (1980 to 2001). The single case of FGN tron microscopy was performed with a Philips 300 (Am-
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sterdam, The Netherlands) or JEOL 100S electron mi- titis or cirrhosis (5%). A single patient had history of
systemic lupus erythematosus, but lacked renal biopsycroscope (Tokyo, Japan). Fibril diameter was measured
with a hand-held magnification graticule (Graticules Ltd., findings of lupus nephritis. Other autoimmune or in-
flammatory conditions included thyroiditis in three pa-Tonbridge, UK) by averaging the measurements in 10 high-
power fields and correcting for the magnification of the tients, rheumatoid arthritis in one patient, temporal arte-
ritis in one patient, gout in two patients, bronchiectasisnegative and the factor of print enlargement. Only fibrils
with distinct borders cut in cross-section were measured. in one patient, and intravenous drug abuse in two pa-
tients. No patient had clinical or serologic evidence ofClinical data were gathered retrospectively by review
of hospital charts and office charts of the referring human immunodeficiency (HIV) infection. One patient
who had undergone a kidney transplant 12 years earliernephrologists. Follow-up information was obtained on
all but four cases. The following clinical definitions were for ESRD of unknown etiology developed FGN in her
transplanted kidney, although it could not be ascertainedused. Renal insufficiency was defined as serum creatinine
1.5 mg/dL; hypertension as blood pressure 140 whether this represented de novo or recurrent disease.
The incidence of diabetes mellitus was 20%; however,mm Hg systolic or 90 mm Hg diastolic; nephrotic syn-
drome as 24-hour urinary protein 3.5 g accompanied no patient had renal biopsy findings of diabetic nephrop-
athy. Although 17% of patients tested had antibodies toby edema and serum albumin3.5 gm/dL; microhematu-
ria as 5 red blood cells (RBC)/ high-power field on hepatitis C, only three patients (5%) had clinical evi-
dence of active hepatitis. Fifteen percent of those testedurinalysis.
Statistical analysis was performed using nonparamet- had a monoclonal protein identified in the serum or
urine. Sixteen percent had a positive antinuclear anti-ric exact statistical methods, including the Fisher exact
test and the Kruskal-Wallis test for categorical variables body (ANA), which was of low titer (1:160) in all but
two cases and was never accompanied by hypocomplem-and the Mann-Whitney test for continuous variables,
where appropriate. Comparison among multiple groups entemia. A single patient had hypocomplementemia (re-
duced serum C3). One patient had a positive test forwith normally distributed data was performed by one-
way ANOVA with post-hoc analysis using tests where serum cryoglobulins. No patient with FGN had clinical or
pathologic evidence of systemic involvement by fibrillaryequal variance is not assumed (Tamhane’s T2 and Dun-
nett’s T3). Multivariate analysis was performed by logistic deposition.
Renal manifestations at the time of biopsy (Table 1)regression analysis with end-stage renal disease (ESRD)
as the dependent variable and by the Cox proportional included renal insufficiency in 44 of 61 (72%) patients,
with mean serum creatinine 3.1  0.34 mg/dL (range,hazards model with risk of progression to ESRD over
time as the dependent variable. Survival analysis was 0.5 to 14 mg/dL). Thirty-six patients (59%) were hyper-
tensive at presentation. All patients presented with pro-performed by the method of Kaplan-Meier using the
log-rank test for analysis of statistical significance. Analy- teinuria, with mean urinary protein 6.48  0.60 g/day
(range, 0.84 to 25 g/day). Among the 53 patients forsis was performed using SPSS v11.0 (SPSS, Chicago, IL,
USA) and STATXact v5.0 (Cytel Software Corp., Cam- whom adequate data are available, 28 (52%) had full
nephrotic syndrome. Mean serum albumin was 3.14 bridge, MA, USA). Statistical significance was assumed
at P  0.05. 0.09 g/dL (range, 1.3 to 4.4 g/dL) and mean serum choles-
terol was 256  9.61 mg/dL (range, 146 to 421 mg/dL).
Hematuria was present in 60% (33/55) of patients with
RESULTS
documented urinalysis, including two patients with gross
Clinical features of FGN hematuria.
The diagnosis of FGN was made in 0.6% of 10,108
Clinical features of ITnative kidney biopsies accessioned by the Renal Pathol-
ogy Laboratory of Columbia University from 1980 to IT comprised only 0.06% of all native kidney biopsies.
Of the six patients with IT, five were female (83%) and2001. The single case of FGN identified in a renal allo-
graft was also included in the study. Patients with FGN five were Caucasian. Other medical conditions and sero-
logic findings are summarized in Table 1. Renal findingsincluded 24 males and 37 females (total, 61 patients) age
28 to 81 years old (mean, 56.8  1.6 years). These in- at presentation were similar to those of FGN; however,
patients with IT had a significantly higher incidence ofcluded 56 Caucasian, three African American, and two
Hispanic patients. Associated medical conditions and serum or urine monoclonal gammopathy, (67% vs. 15%)
(P 0.014), underlying lymphoproliferative disease (Pserologic findings are summarized in Table 1. There was
a low incidence of underlying nonhematologic malignan- 0.020) and hypocomplementemia (33% vs. 2%) (P 
0.032) (Table 1). Of the four patients with monoclonalcies (5%) (including one each of lung, colon, and renal
cell carcinomas), lymphoproliferative disease (2%), my- gammopathy, one had chronic lymphocytic leukemia;
two had negative bone marrow biopsies; and one hadeloproliferative disease (2%), vasculitis (3%), and hepa-
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Table 1. Clinical parameters
Initial clinical parameters Fibrillary (N  61) Immunotactoid (N  6) P value
Age years 56.8 (28–81) 66.3 (44–86) NS
Female 37 (61%) 5 (83%) NS
Race
Caucasian 56 (92%) 5 (83%) NS
African American 3 (5%) 1 (20%) NS
Hispanic 2 (3%) 0 NS
Renal insufficiency 42 (69%) 5 (83%) NS
Creatinine mg/dL 3.1 (0.5–14) 2.1 (1.4–3.8) NS
24-hr urine protein gm/day 6.4 (.84–25) 8.7 (2.3–24) NS
Proteinuria  2 gm/day 52/57 (91%) 6/6 (100%) NS
Edema 41 (67%) 4 (67%) NS
Serum albumin g/dL 3.1 (1.3–4.4) 2.7 (1.1–3.7) NS
Serum cholesterol mg/dL 256 (146–421) 236 (188–293) NS
Nephrotic syndrome 28/53 (52%) 3 (50%) NS
Hypertension 47 (77%) 3 (50%) NS
Hematuria 33/55 (60%) 5 (83%) NS
Associated medical conditions
Diabetes mellitus 12 (20%) 1 (17%) NS
Lymphoproliferative diseasea 1 (2%) 2 (33%)  0.020
Carcinomas 3 (5%) 0 NS
Systemic lupus erythromatosus 1 (1.6%) 1 (17%) NS
Autoimmune/vasculitis 2 (3%) 1 (17%) NS
Cirrhosis/hepatitis 3 (5%) 0 NS
HIV 0 1 (17%) NS
Positive serologies
Hepatitis C 6/34 (17%) 1/5 (20%) NS
Monoclonal spike (SPEP) 6/45 (13%) 4/6 (67%)  0.006
Monoclonal spike (UPEP) 4/35 (11%) 2/5 (40%) NS
SPEP or UPEP 7/46 (15%) 4/6 (67%)  0.014
Antinuclear antigen 7/44 (16%) 0/4 (0%) NS
Cryoglobulins 1/27 (4%) 0/6 (0%)b NS
Low complements 1/46 (2%) 2/6 (33%)  0.032
All results reported as mean (range) or number (%). Abbreviations are: SPEP, serum protein electrophoresis; UPEP, urine protein electrophoresis.
a Defined as lymphoproliferative disorder confirmed by bone marrow biopsy
b One case of immunotactoid glomerulonephritis subsequently developed cryoglobulinemia several months after the renal biopsy
mild plasmacytosis on bone marrow biopsy, but did not little or no mesangial hypercellularity (Fig. 2D). Trans-
membranous penetration of fibrils, which can mimickmeet criteria for multiple myeloma. One of the IT pa-
tients with hypocomplementemia had known HIV and membranous glomerulopathy by light microscopy, was
considered insufficient to qualify as the MGN pattern.hepatitis C virus co-infection and had had two negative
cryoglobulin determinations at the time of renal biopsy. Thirteen percent of biopsies had a nondescript diffuse
sclerosing pattern (DS), defined as glomerular sclerosisHowever, a mixed cryoglobulin was identified on a third
determination performed 2 months later. obliterating 70% of glomeruli (Fig. 2E). In the DS
group, a mean of 87% of glomeruli exhibited advanced
Renal biopsy findings sclerosis. For all histologic subgroups, the glomerular
deposits typically exhibited tinctorial properties resem-Light microscopy. FGN biopsies manifested diverse
bling amyloid with routine stains [glassy and weakly eo-histologic patterns (Table 2). The most common pattern,
sinophilic, weakly periodic acid-Schiff (PAS)–positive,found in 44% of biopsies, was membranoproliferative
gray-purple on trichrome stain, and nonargyrophilic];glomerulonephritis (MPGN) defined by mesangial expan-
however, all cases were Congo red–negative.sion with foci of mesangial interposition and replication
Thirty-one percent of all FGN cases had cellular orof glomerular basement membrane (Fig. 2A). Twenty-
fibrocellular crescents. Crescents were most frequentlyone percent of biopsies had exclusively mesangial prolif-
identified in the DPGN subgroup, in which crescentseration or sclerosis (MES) (Fig. 2B). Fifteen percent
involved mean 25% (range, 0% to 57%) of glomeruli.of patients had a diffuse proliferative (DPGN) pattern
characterized by endocapillary proliferation including Crescents also involved mean 4.7% of glomeruli with
MPGN pattern, 3.5% of glomeruli with MGN pattern,focal infiltrating leukocytes (Fig. 2C). A relatively un-
common pattern was membranous (MGN) (7%), featur- but no example of MES. Interstitial disease was most
severe in the DS subgoup, in which all biopsies (100%)ing predominantly subepithelial fibrillar deposits sepa-
rated by well-formed basement membrane spikes, with displayed moderate to severe interstitial fibrosis, fol-
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lowed by MPGN (74%), MES (61%), DPGN (56%),
and MGN (25%).
Of the six cases of IT, three (50%) had an MPGN
pattern (one with associated membranous features) and
three (50%) exhibited a DPGN pattern (of which two
had associated membranous features) (Fig. 2F). Cres-
cents were not identified in any IT case.
Immunofluorescence microscopy. Among the FGN
cases, all stained with antisera to immunoglobulins and
96% displayed glomerular positivity for IgG, with mean
intensity of 2.19 (scale 0 to 3
). Fifty-two percent of
cases were reactive for IgM (mean intensity of positive
cases, 1.04), 30% for IgA (mean intensity, 0.72). C3 was
detected in 83% of cases (mean intensity, 1.76), com-
pared to 41% reactivity for C1q (mean intensity, 0.98).
In 96%, there was staining for both kappa and lambda
light chains, without evidence of light chain predomi-
nance. However, in one case, only kappa light chain was
identified, and in another only lambda light chain was
identified, each with 1
 intensity. The texture of the
staining by immunofluorescence was typically smudged
without distinct linearity or granularity.
Among the IT cases, all six displayed glomerular posi-
tivity for IgG (mean intensity, 2.20), three of six for IgM
(mean intensity of positive cases, 1.17), two of six for
IgA (mean intensity, 0.75), six of six for C3 (mean inten-
sity, 1.33), and four of six for C1q (mean intensity, 1.13).
Four cases (66%) showed monoclonal IgG deposition
with light chain restriction (three kappa, one lambda).
All four of these patients had a monoclonal protein (3
IgG and 1 IgG) identified in their serum, and two also
had free kappa light chain in the urine. The other two
cases had glomerular staining for both kappa and lambda
light chains, without evidence of light chain predomi-
nance. One of the latter cases was a patient with hypo-
complementemia and co-infection with HIV and hepati-
tis C virus, who was later documented to have a circulating
mixed cryoglobulin.
Electron microscopy. The mean diameter of the glo-
merular fibrils was 20.1  0.4 nm (range, 13 to 29 nm)
in the 61 cases with FGN. Fibrils were most commonly
detected in the mesangium (98%) or within the glomeru-
lar basement membrane (92%), with subepithelial or
subendothelial distribution in only 13% of cases. Fibrillar
deposits were identified in the tubular basement mem-
branes in only 5% of cases. In no case were fibrils identi-
fied in Bowman’s capsule or the walls of arteries or
interstitial capillaries. In all cases the fibrils were ran-
domly arranged and closely intermingled with the matrix
material of the mesangium or glomerular basement
membrane. Fibrils were often deposited on a background
of more granular, amorphous electron dense deposits.
In IT, the mean diameter of the microtubules was
38.2 nm  5.7 (range, 20 to 55 nm). One case with
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microtubules of 20 nm diameter was classified as IT
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rather than FGN because of the presence of hollow cen- For IT, cases were too few to permit analysis of corre-
lations between histologic findings and presenting clini-ters and arrangement of the microtubules in parallel
arrays. Among the six IT cases, five had mesangial depos- cal features.
its, three had intramembranous deposits, six had suben-
Outcomedothelial deposits, and three had subepithelial deposits.
No microtubules were identified in the tubular basement Of the patients with FGN, five patients were lost to
follow-up. The remaining 56 patients were followed formembranes, Bowman’s capsule, or walls of blood vessels
or interstitial capillaries. a mean of 23 months (0 to 128 months). Twenty-five
patients (45%) developed ESRD. While only 18% ofIgG subtyping. Staining for the IgG subtypes was per-
formed on 19 FGN cases for which residual frozen tissue patients who presented without renal insufficiency (cre-
atinine 1.5 mg/dL) progressed to ESRD, 72% (23/32)was available. Monotypic deposits composed of a single
gamma subtype were found in four cases (two IgG1 and of patients who presented with a creatinine  2.0 mg/dL
reached ESRD. The median time to ESRD was 24.4 two IgG4). Oligotypic deposits (containing both IgG1
and IgG4, but not IgG2 or IgG3) were found in the 15.2 months (mean, 57.6  9.49 months). Mean time to
ESRD varied according to histologic subtype (P remaining 15 cases (Fig. 3 A to D). All 19 had apparently
polyclonal deposits (with equivalent staining for kappa 0.001), (Fig. 4). The histologic subgroups of DS, DPGN,
and MPGN progressed more rapidly to ESRD (mean,and lambda light chain). By contrast, among a control
group of 80 biopsies with lupus nephritis, 81.3% stained 7 months, 20 months, and 44 months, respectively) com-
pared to MES and MGN (mean, 80 months and 87for IgG1, 88.8% for IgG2, 96.3% for IgG3, and 36.3%
for IgG4. No lupus nephritis case had staining for IgG1 months, respectively). On univariate analysis, outcome
correlated significantly with a number of factors, includ-alone or IgG4 alone. Moreover, no lupus case had co-
positivity for IgG1 and IgG4, with negativity for IgG2 ing histologic subtype (P  0.001) (Table 3). On multi-
variate Cox regression analysis, only serum creatinine atand IgG3.
Among the five cases of IT with frozen tissue available biopsy (P 0.001) and severity of interstitial fibrosis (P
0.034) correlated with outcome (Table 4).for IgG subtype staining, four cases contained mono-
clonal deposits of IgG1 subclass (including three IgG1 The six patients with IT were followed for a mean of
10 months (2 to 20 months). One patient who presentedkappa and one IgG1 lambda) (Fig. 3 E and F). One of
these four cases had monoclonal (3
) staining for IgG1 with a creatinine of 2.2 mg/dL progressed to ESRD in
2 months. The other patients have persistent, significantkappa in a membranous pattern in the single non-scle-
rotic glomerulus sampled, however there was 1
 IgG1, renal insufficiency, without progression to ESRD. The
mean renal survival for the IT group was 17.2 months.1
 IgG2, trace IgG3, and trace IgG4 in several globally
sclerotic glomeruli. Interestingly, this patient was known The number of IT patients is too small to analyze statisti-
cally the differences in outcome between IT and FGN.to have had a past history of systemic lupus and biopsy-
documented lupus nephritis in 1993, 7 years before the
Treatmentdevelopment of monoclonal IgG  monoclonal gammo-
pathy and the repeat biopsy containing microtubular de- Among FGN patients, 20 of 56 (36%) received immu-
nosuppressive therapy, including steroids alone in 16%,posits of monoclonal IgG . The fifth case with HIV and
hepatitis C virus co-infection had oligotypic deposits of cyclophosphamide (with or without steroids) in 14%,
and cyclosporine in 5%. The type of immunosuppressiveIgG2 and IgG3, with negativity for IgG1 and IgG4.
therapy offered was generally tailored to histologic sub-
Clinicopathologic correlations at presentation type. Steroids alone or cyclophosphamide were offered
only to patients with DPGN (22% received steroidsIn FGN, histologic pattern correlated with both the
severity of renal insufficiency and the amount of protein- alone and 56% received cyclophosphamide), MPGN
(15% received steroids alone and 4% received cyclo-uria at presentation (Table 2). Presenting mean serum
creatinine was higher in the DS, DPGN, MPGN cases phosphamide), MES (15% received steroids alone and
15% received cyclophosphamide). Cyclosporine was of-(5.1 mg/dL, 4.1 mg/dL, and 3.3 mg/dL, respectively) when
compared with MES and MGN (1.7 mg/dL and 0.8 fered to patients with MGN (50%) and DS (13%).
The use of immunosuppressive therapy did not corre-mg/dL). Mean proteinuria was higher in the patients with
MPGN, DPGN, and DS (8.2 g/day, 6.7 g/day, 5.7 g/day, late with outcome parameters, including incidence of
ESRD or time to ESRD in any histologic subgroup.respectively) when compared with MES and MGN (4.7
g/day and 3.6 g/day). Seventeen of 23 (74%) patients Nevertheless, an apparent partial response to therapy
was found in several individuals. In one FGN patientwith MPGN had full nephrotic syndrome, followed by
five of seven (71%) patients with DPGN, four of seven with DPGN, serum creatinine fell from 6.2 mg/dL to
2.6 mg/dL following an 8-month course of intravenous(57%) patients with DS, one of three (33%) of those
with MGN, and only one of 13 (8%) of those with MES. cyclophosphamide and prednisone, although he ulti-
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Fig. 2. Light microscopic features of fibrillary glomerulonephritis (FGN) and immunotactoid glomeronephritis (IT). (A) The most common histologic
pattern of FGN is membranoproliferative glomerulonephritis, with mesangial proliferation and increased mesangial matrix, double contours of
the glomerular basement membrane, and mesangial interposition (Jones methenamine silver, 400). (B ) The mesangial pattern of FGN is
characterized by mild mesangial expansion composed of mesangial cells and matrix. The glomerular capillary lumina are patent and glomerular
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mately progressed to ESRD despite a second course of confirm a number of observations from earlier, smaller
immunosuppressive therapy. In a second FGN patient published series. The incidence of FGN of 0.6% of renal
with MPGN pattern, creatinine fell from 7.3 mg/dL to biopsies is similar to the incidence of 1% reported by
4.8 mg/dL following 6 months of intravenous cyclophos- Iskandar, Falk, and Jennette [2] and Fogo, Qureshi, and
phamide and prednisone. A patient with DS was treated Horn [10]. We found a slight female preponderance
with 5 months of cyclosporine followed by a fall in her (male:female ratio, 1.0:1.5) similar to the ratio of 1.0:1.3
proteinuria from 5.8 g/day to 2.0 g/day; however, creatinine in a compilation of reported cases reviewed by Brady
rose from 1.9 mg/dL to 2.7 mg/dL during the treatment [3]. Our strong Caucasian racial predominance of 11:1
period. One FGN patient with MGN pattern, normal is also similar to the 9:1 ratio reported by Brady [3]. The
serum creatinine, and the nephrotic syndrome had a mean age at presentation of 57 years is only slightly
partial response to steroids with a fall in proteinuria from higher than the mean ages of 49 to 51 years reported in
6.3 g/day to 3.2 g/day, followed by a further decline to other series [2, 10, 11].
1.3 g/day following an 18-month course of cyclosporine. Patients presented with high-grade proteinuria (mean,
Three patients with IT who had monoclonal IgG de- 6.5 g/day) at biopsy, similar to that reported in several
posits (two IgG  and one IgG ) and monoclonal gam- other series [2, 10, 11]. Fifty-two percent of our patients
mopathy received treatment for their hematologic disease.
had full nephrotic syndrome and 60% had hematuria,One patient was treated with melphalan and prednisone
slightly less than the rates of 71% and 70%, respectively,and one with prednisone and immuran, followed by cell-
reported by others [3]. Renal insufficiency was identifiedcept. Both of these patients did not show any obvious
at presentation in 72% of cases, and the mean serumresponse to therapy as measured by stabilization of renal
creatinine of 3.1 is similar to that reported by severalfunction or decrease in proteinuria. However a third
groups [2, 10, 11].patient with CLL was treated with a course of fludara-
Our findings confirm the high risk of ESRD in FGN,bine and had a decrease in proteinuria from 7.8 g/day
with a median renal survival in our patients of only 24to 1.8 g/day and a fall in creatinine from 3.8 mg/dL to
months from the time of biopsy. Our series is the first1.7 mg/dL 3 months later.
to document the utility of subcategorizing the diverse
Transplantation light microscopic patterns of FGN. MPGN was the most
frequent histologic pattern (44%), followed by MESTwo patients received cadaveric kidney transplants
(21%), DPGN (15%), DS (13%), and MGN (7%). Theduring the follow-up period. One patient had no clinical
predominant histologic pattern on biopsy correlated withevidence of recurrence after 8 years, with normal serum
creatinine and no proteinuria. The other patient died 4 clinical features on presentation including the severity
years after transplantation due to colon cancer with a of renal insufficiency, the amount of proteinuria, and the
stable creatinine of 2.2 mg/dL at the time of death. Be- incidence of nephrotic syndrome. We also found that
cause of stable graft function and absence of proteinuria, clinical outcomes, in terms of the percentage of patients
neither patient was subjected to allograft biopsy. reaching ESRD and the mean time to ESRD, correlated
One patient was diagnosed with FGN in her allograft with histologic pattern. Not surprisingly, patients who
after having received a living-related donor transplant had advanced sclerosis (DS) or severe proliferative fea-
12 years prior. The cause of her initial renal failure was tures (DPGN or MPGN) had the worst prognosis. Con-
unknown. Because her native kidney disease had its clini- versely, patients with MGN and MES had both a lower
cal onset at age 11, it is unlikely that her original renal risk of progression to ESRD and a slower rate of progres-
disease was FGN. She experienced progressive graft fail- sion. The diversity of histologic subtypes and correlation
ure despite the addition of oral cyclophosphamide to
with outcome is reminiscent of the pleomorphic renaltreat her FGN.
pathologic findings in lupus nephritis. We believe that
classifying FGN patients in a manner analogous to the
DISCUSSION World Health Organization (WHO) classification for lu-
pus nephritis is useful to estimate risk of progression [13].Our series represents the largest single-center series
on FGN and IT published to date. Our data on FGN A mesangial or membranous lesion would be considered

basement membranes are of normal thickness [periodic acid-Schiff (PAS),400]. (C) The diffuse proliferative pattern of FGN has global endocapillary
proliferation, including infiltrating leukocytes. There is segmental fibrinoid necrosis with karyorrhexis. An early, segmental cellular crescent is seen
(at top) [hematoxylin and eosin (H&E),400]. (D ) The membranous pattern of FGN has a normocellular tuft with global thickening of glomerular
capillary walls, which contain spike-like projections of glomerular basement membrane material (Jones methenamine silver,650). (E ) The diffuse
sclerosing pattern exhibits diffuse and global solidification of the glomerular tuft by glassy PAS-positive material, with loss of cellular elements
(PAS, 120). (F ) An example of IT displays mixed membranoproliferative and membranous pattern with lobular accentuation, marked mesangial
expansion by cells and weakly PAS-positive deposits, and glomerular basement membrane thickening (PAS, 400).
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Fig. 3. Immunoglogulin G (IgG) subtyping in fibrillary glomerulonephritis (FGN) and immunotactoid glomeronephritis (IT). Representative
glomerulus from a case of FGN shows high intensity, global mesangial and capillary wall positivity for IgG1 (A ), negativity for IgG2 (B ) and
IgG3 (C ), and similar high intensity positivity for IgG4 (D ). The texture of the staining is “smudgy,” without distinct granularity or linearity. A
case of IT with monoclonal IgG lambda deposits shows positivity for IgG1 (E ) in a mesangial and capillary wall distribution. There was negativity
for IgG2 (F ), IgG3 (not shown), and IgG4 (not shown) (all magnifications 400).
analogous to class II and V lupus nephritis, with a lower logic subtypes are not a function of intrinsic differences
in disease biology, but rather reflect differences in activ-risk of progressive renal failure than those with prolifera-
tive histologies akin to class III and IV lupus nephritis. ity and chronicity.
We could not demonstrate a statistical benefit of treat-Similarly, the DS form can be considered analagous to
advanced lupus nephritis class VI. It is likely that the ment in this uncontrolled retrospective analysis. It is
likely that the advanced degree of renal damage, as indi-observed differences in outcome between these histo-
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Fig. 4. Kaplan-Meier survival analysis in fibril-
lary glomerulonephritis (FGN) and its histologic
subtypes. Abbreviations are: ESRD, end-stage
renal disease; MPGN, membranoproliferative
glomerulonephritis; MES, mesangial prolifer-
ative/sclerosing; DPGN, diffuse proliferative
glomerulonephritis; MGN, membranous glo-
merulonephritis; and DS, diffuse sclerosing.
Table 4. Correlates of end-stage renal disease (ESRD) in fibrillaryTable 3. Correlates of end-stage renal disease (ESRD) in fibrillary
glomerulonephritis (FGN)—Univariate analysis glomerulonephritis (FGN)–Multivariate Cox regression
P valueP value
Histologic subtype 0.001 Serum creatinine 0.001
Interstitial disease 0.034Nephrotic syndrome 0.007
Severity of interstitial disease 0.001
Presence of crescents 0.001
Percentage of crescents 0.001
Hematocrit 0.007 ing renal characteristics were similar between FGN and
Proteinuria 0.001
IT, there were statistically significant differences withSerum creatinine 0.001
Serum albumin 0.001 respect to the incidence of associated monoclonal gam-
Percentage of glomerulosclerosis 0.009 mopathy, hematologic malignancy, and hypocomple-
Abbreviations are: SPEP, serum protein electrophoresis; UPEP, urine protein mentemia. These differences are reflected in the differing
electrophoresis.
immunopathologic composition of the glomerular de-
posits, which consisted of monoclonal IgG in 67% of
IT cases. Whereas some investigators have argued thatcated by the mean serum creatinine of 3.1 mg/dL in FGN,
monoclonal gammopathy should be an exclusion crite-contributed to the poor therapeutic response. However,
rion for IT [3, 8, 11], we disagree with that approach.several of our FGN patients had a transient response to
How should cases of monoclonal microtubular depositstherapy with cyclophosphamide or cyclosporine. Most
be classified, if not as IT? Microtubules are not a definingdramatically, one patient with IT and underlying CLL,
feature of Randall’s type monoclonal immunoglobulinwho had monoclonal glomerular deposition of IgG
deposition disease [15]. The large diameter and Congolambda, exhibited an impressive response to treatment
red–negativity of the organized deposits is inconsistentwith fludarabine, a nucleoside analog and potent anti-
with renal amyloidosis. Finally, all six patients lackedlymphocyte agent. This case is of particular interest given
an identifiable cryoglobulin at the time of renal biopsy,our recent observations of favorable response to fludar-
disqualifying them from categorization as a form of cry-abine in patients with type 2 cryoglobulinemia and glo-
oglobulinemic glomerulonephritis, (although the singlemerulonephritis [14]. Prospective controlled study of a
case with oligotypic deposits of IgG2 and IgG3 was dem-larger group of FGN and IT patients pooled from multi-
onstrated to have a mixed cryoglobulin months later).ple centers is needed to determine the potential benefit
The category of IT appears most appropriate for thisof therapy and to define the optimal therapeutic regimen.
group and serves the useful purpose of identifying pa-There is considerable controversy about the relation-
tients with a high probability of underlying dysproteine-ship of FGN to IT. Our series attests to the extreme
mia or occult cryoglobulinemia.rarity of IT (0.06%) compared to FGN (0.6% of native
Cases of IT had microtubules that varied from 20 tokidney biopsies), an entity that is approximately tenfold
more common, but nonetheless rare. Although present- 55 nm in diameter, and all but one case had microtubules
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of 30 nm. Thus, although the range of microtubule of FGN patients [22], and raises the question of a “slow
cryoglobulin,” a concept proposed by Rostagno et aldiameter in IT overlapped slightly with that of FGN at
its lowest reaches, more important criteria for distin- [23]. Some cryoglobulins may be difficult to detect be-
cause they require longer than four days at 4C for pre-guishing IT from FGN were the presence of hollow cen-
ters and the formation of parallel arrays in IT. cipitation [23], or because they require the unique micro-
environment of the glomerular filter. Fibril depositionTo our knowledge, only 15 patients with FGN under-
going transplant have been reported to date [11, 16–18]. in both IT and FGN is generally limited to the kidney,
although there have been rare reports of fibrils found inA high incidence of recurrence (47% of allografts) has
been reported [17], supporting the role of a circulating other tissues, including lung, liver, and bone marrow
[24–26]. No patient in our series had clinical evidenceor systemic factor. Only three patients lost their allo-
grafts due to recurrent disease 5 to 13 years after trans- of fibril deposition in other organs, and only 5% had
evidence of tubular basement membrane deposits. Theplant, whereas the others maintained stable or normal
renal function up to 8 years posttransplant, indicating a renal-limited, and exclusively glomerular, deposition ob-
served in the vast majority of cases of FGN suggests therelatively indolent course of recurrent FGN in the allo-
graft [17]. Of the two patients in our series who were potential importance of glomerular sieving to concen-
trate circulating immune reactants at the level of thetransplanted due to known FGN, neither was rebiopsied
and neither had clinical evidence of recurrence. A third glomerular capillary, where unique matrix interactions
with fibronectin or other basement membrane compo-case probably represents the first example of de novo
FGN in the allograft, (although a single case of de novo nents may occur. Of interest, one of our patients with
FGN and MPGN pattern developed purpura due to leu-IT in the allograft has been reported) [19].
Our findings confirm that the glomerular deposits in kocytoclastic vasculitis several months after initial renal
biopsy, with negative serologies (including ANA, ANCA,FGN have dominant staining for IgG and C3, with
weaker and more variable positivity for IgM, IgA, and hepatitis C virus, and cryoglobulins). To our knowledge
this is the first association of vasculitis with FGN, al-C1q. The staining for both kappa and lambda light chain
in all but two cases supports the polyclonal nature of though there are rare reports of vasculitis associated with
IT [27, 28].the deposits [20]. These findings are in agreement with
the immunoelectron microscopic observations by Yang
et al [21] showing decoration of individual fibrils with
CONCLUSION
immunogold labeling for IgG, kappa and lambda light
FGN is an idiopathic glomerular disease characterizedchains, as well as amyloid P component, which may play
by randomly arranged Congo red–negative fibrils ofa role in fibrillogenesis or resistance to proteolysis.
mean 20 nm diameter. Glomerular deposits are predomi-Iskandar, Falk, and Jennette [2] noted that the immune
nantly composed of polyclonal IgG and C3, with strongdeposits in FGN were almost exclusively composed of
evidence of monotypic or oligotypic IgG subclass restric-the IgG4 subclass, with few cases also staining weakly for
tion. IT is defined by glomerular deposition of generallyIgG1. Our data confirm that the IgG deposited in FGN
larger microtubules that are composed of monoclonalis subclass-restricted; however, we found only 10.5% of
IgG in the majority of cases. Although renal presentationcases to be composed exclusively of monotypic IgG1 or
of FGN and IT are similar, patients with IT are moreIgG4 and 78.9% to have oligotypic deposits of both IgG1
likely to have dysproteinemia, hypocomplementemia,and IgG4. This was in dramatic contrast to the findings
and occult cryoglobulinemia. Based on these importantin diffuse proliferative lupus nephritis where all four
clinical and immunopathologic distinctions and their im-IgG subclasses were represented and IgG4 was never
plications for patient management, we believe the differ-dominant. The homogeneous nature of the IgG deposi-
entiation of FGN from IT is useful and well justified.tion with respect to subclass may promote fibrillogenesis
through the deposition of immunoglobulin proteins with Reprint requests to Vivette D. D’Agati M.D., Columbia University,
College of Physicians and Surgeons, Department of Pathology, Roomsimilar structural and physicochemical properties. The
VC14-224, 630 West 168th Street, New York, NY 10032homogeneous physical properties of the IgG deposits
E-mail: vdd1@columbia.edu
may prevail despite the apparently polyclonal composi-
tion of the immune deposits.
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